Topic: Manufacturing jobs
Merck's expansion of Gardasil production in Virginia and now in North Carolina means $1.68 billion in investments and 525 new jobs.
A manufacturing facility that Novartis discarded because of declining generics sales is getting a new life producing CBD products.
Boehringer Ingelheim has invested €225 million on inhaler production with a new plant in Spain and expanded lines in Germany.
KriGen Pharmaceuticals plans to build a $7 million facility in Lillington, North Carolina.
GlaxoSmithKline will unload an API plant to Thermo Fisher Scientific for €90 million. The U.S. company says it is glad to get it.
Allergan is finishing a $156.2 million investment in a biologics manufacturing facility at its Westport, Ireland, site while adding 63 jobs.
A Lithuanian CDMO is investing €50 million in its biologics manufacturing site and adding up to 80 jobs.
U.K.-based CDMO Almac is adding to its U.S. operations with a new building at its site in North Carolina where it says it will house 100 new employees.
Pfizer, which is building a large pharmaceutical manufacturing facility, is seeking a tax break from local and state governments.
Teva Pharmaceutical is facing ongoing protests at its operations in Israel after it announced global layoffs that are expected to reach some 14,000 employees over the next year.